data

Partner Content

Real-world-evidence-rare-disease-pharmaphorum

Partner Content

Real-world evidence: breaking boundaries in rare disease

The COVID-19 pandemic has added a new layer of complexity to the drug development process.

Views & Analysis

A collaborative approach to greater diversity in clinical tr...

The need for diversity in clinical trial populations has been a topic of discussion across regulators and the industry in general for decades.

Views & Analysis

True patient-focused research through decentralised and hybr...

How can pharma improve the patient-centricity of its trials during COVID-19 and beyond?

Views & Analysis

Pharma’s digital transformation journey and the role of cust...

Better management of customer data could help pharmaceutical companies’ digital transformation, according to Veeva’s Rebecca Silver.

News

Takeda to partner on patient-centric data with Seqster

Takeda has partnered with patient data firm Seqster in a drive to improve care through better access and understanding of patient-level data.

Views & Analysis

Why 72% of patients don’t feel listened to by pharma

Claus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks what a truly effective feedback loop for medicines might look like.

Real-world evidence: breaking boundaries in rare disease

A collaborative approach to greater diversity in clinical tr...

True patient-focused research through decentralised and hybr...

Pharma’s digital transformation journey and the role of cust...

Takeda to partner on patient-centric data with Seqster

Why 72% of patients don’t feel listened to by pharma

Novo Nordisk fight with KBP Bio will go to arbitration

Discover a new era of healthcare panel engagement: Grounded ...

data

Editor's Picks